Health care

Showing of Insights Posts
nilesh-kumar1
Video
3 min
Innovation Venture capital Biotech Private Investing Program Private investing Video Private Biotech
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech innovation versus hype

Nilesh Kumar discusses the next generation of biotech disruptors in obesity, autoimmunity, and oncology, focusing on drugs that solve real-world unmet medical needs.

Continue reading

By

Nilesh Kumar
Nilesh Kumar, PhD
event
3 min
Video
2026-06-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1370499454
Article
8 min
Health care Macro and market Fiscal policy Content CoE Program Global Program USA Inflation Wellington on Washington and the World Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Shrinking the government footprint: Medicaid cuts and America’s economic health

Macro Strategist Juhi Dhawan looks at what changes to the mammoth US Medicaid program could mean for economic growth, employment, inflation, and financial markets.

Continue reading

By

Juhi Dhawan
Juhi Dhawan, PhD
event
8 min
Article
2026-03-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1271246974
Video
2 min
Health care Private companies Venture capital Private Investing Program Private investing WELLSaid Podcast Video
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

The role of public/private collaboration

Josh Sommerfeld, health care sector lead for late-stage private investments, highlights why he believes working with public-market colleagues like Dave Khtikian helps him be better at the four key parts of his job: sourcing, diligence, pricing, and exiting.

Continue reading

By

Thomas Mucha
Thomas Mucha
Josh Sommerfeld
Josh Sommerfeld
event
2 min
Video
2026-01-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1349253411
Article
5 min
Private Biotech Liquid alternatives & hedge funds Biotech Health care Venture capital Article Innovation Private investments Private Investing Program Private equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Immunology and inflammation’s third wave

Our experts discuss how I&I is building on industry progress to offer new treatment solutions and interesting opportunities for private biotech investors. 

Continue reading

Multiple authors

event
5 min
Article
2025-12-01
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
97970762
Article
8 min
Small-cap Global Industry Research Biotech Institutional Program Discover Large-cap Thematic solutions Article Equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.

Continue reading

By

Wen Shi
Wen Shi, PhD, CFA
Mark Sevecka
Mark Sevecka, PhD
event
8 min
Article
2025-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2032712798
Article
4 min
Private investing Private Biotech Biotech Venture capital Article Private Investing Program Private companies Private equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.

Continue reading

By

Nilesh Kumar
Nilesh Kumar, PhD
William Craig
William Craig
event
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1413597282
Article
14 min
Private investing Health care Late-stage growth Venture capital Article Private investments
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Built to last? Identifying durable health care start-ups

Two members of our late-stage growth team share insights and results from their recent analysis of enterprise-value trajectories for private, non-biotech health care companies.

Continue reading

By

Josh Sommerfeld
Josh Sommerfeld
Jahon Rafian
Jahon Rafian
event
14 min
Article
2025-05-23
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
7 LOAD {count} MORE

URL References

Related Insights

© Copyright 2025 Wellington Management Company LLP. All rights reserved. WELLINGTON MANAGEMENT ® is a registered service mark of Wellington Group Holdings LLP. For institutional or professional investors only.

View More